Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension.

P L Drury

    Bailliere'S Clinical Endocrinology and Metabolism
    |May 1, 1988
    PubMed
    Summary
    This summary is machine-generated.

    Hypertension management in non-insulin-dependent diabetes mellitus (NIDDM) is crucial. While benefits are likely, specific data are lacking, and other risk factors like smoking require attention.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Association of type 2 diabetes with prolonged hospital stay and increased rate of readmission in patients with lower limb cellulitis.

    Internal medicine journal·2016
    Same author

    Ethnicity and risk of lower limb amputation in people with Type 2 diabetes: a prospective cohort study.

    Diabetic medicine : a journal of the British Diabetic Association·2015
    Same author

    New onset diabetes after transplantation: Not another acronym!

    JRSM open·2015
    Same author

    The Diabetes Excess Weight Loss (DEWL) Trial: a randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes.

    Diabetologia·2012
    Same author

    Reversible severe deterioration of glycaemic control after withdrawal of metformin treatment.

    Diabetologia·2011
    Same author

    Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.

    Diabetologia·2010
    Same journal

    Phytoestrogen content in foods.

    Bailliere's clinical endocrinology and metabolism·1999
    Same journal

    Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data.

    Bailliere's clinical endocrinology and metabolism·1999
    Same journal

    Experimental studies on lignans and cancer.

    Bailliere's clinical endocrinology and metabolism·1999
    Same journal

    Reproductive actions of phytoestrogens.

    Bailliere's clinical endocrinology and metabolism·1999
    Same journal

    Phytoestrogens and inhibition of angiogenesis.

    Bailliere's clinical endocrinology and metabolism·1999
    Same journal

    Phytoestrogens and diseases of the prostate gland.

    Bailliere's clinical endocrinology and metabolism·1999
    See all related articles

    Area of Science:

    • Cardiology
    • Endocrinology
    • Public Health

    Background:

    • Hypertension is a significant risk factor for mortality and morbidity in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    • Yearly blood pressure (BP) measurement is standard practice for NIDDM patients.
    • The precise benefits of antihypertensive therapy in NIDDM remain under investigation.

    Purpose of the Study:

    • To review the current understanding of hypertension management in NIDDM.
    • To discuss the evidence for and against specific treatment thresholds and drug choices.
    • To emphasize the importance of considering other cardiovascular risk factors.

    Main Methods:

    • Literature review and synthesis of existing studies and guidelines.
    • Analysis of data regarding cardiovascular outcomes in diabetic and non-diabetic populations.

    Related Experiment Videos

  • Consideration of risk-benefit analysis for antihypertensive interventions.
  • Main Results:

    • Evidence suggests potential benefits of antihypertensive therapy in NIDDM, particularly for cerebrovascular outcomes at higher diastolic pressures (>105 mm Hg).
    • No conclusive evidence shows reduced coronary artery disease mortality in NIDDM patients with hypertension.
    • Smoking cessation offers greater mortality risk reduction than antihypertensive therapy for most smokers.

    Conclusions:

    • Treatment thresholds for hypertension in NIDDM without nephropathy may not differ from non-diabetic individuals.
    • Other risk factors, including hyperlipidemia and smoking, are critical and may warrant more aggressive management.
    • Individualized antihypertensive therapy selection is essential, considering patient-specific factors and quality of life.